CRISPR techniques and potential for the detection and discrimination of SARS-CoV-2 variants of concern

被引:23
作者
Xiao, Huyan [1 ]
Hu, Jianyu [1 ]
Huang, Camille [1 ]
Feng, Wei [1 ]
Liu, Yanming [1 ]
Kumblathan, Teresa [1 ]
Tao, Jeffrey [1 ]
Xu, Jingyang [1 ]
Le, X. Chris [1 ]
Zhang, Hongquan [1 ]
机构
[1] Univ Alberta, Fac Med & Dent, Dept Lab Med & Pathol, Div Analyt & Environm Toxicol, Edmonton, AB T6G 2G3, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
Bioanalytical assays; Cas proteins; COVID-19; CRISPR; crRNA; Molecular diagnostics; Nucleic acids; Point-of-care test; Ribonucleoprotein; SARS-CoV-2; variants; NUCLEIC-ACID DETECTION; R-LOOP COMPLEX; OFF-TARGET; GUIDE-RNA; DETECTION PLATFORM; DNA CLEAVAGE; CAS9; ENDONUCLEASE; BINDING; SPIKE;
D O I
10.1016/j.trac.2023.117000
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The continuing evolution of the SARS-CoV-2 virus has led to the emergence of many variants, including variants of concern (VOCs). CRISPR-Cas systems have been used to develop techniques for the detection of variants. These techniques have focused on the detection of variant-specific mutations in the spike protein gene of SARS-CoV-2. These sequences mostly carry single-nucleotide mutations and are difficult to differentiate using a single CRISPR-based assay. Here we discuss the specificity of the Cas9, Cas12, and Cas13 systems, important considerations of mutation sites, design of guide RNA, and recent progress in CRISPR-based assays for SARS-CoV-2 variants. Strategies for discriminating single-nucleotide mutations include optimizing the position of mismatches, modifying nucleotides in the guide RNA, and using two guide RNAs to recognize the specific mutation sequence and a conservative sequence. Further research is needed to confront challenges in the detection and differentiation of variants and sublineages of SARS- CoV-2 in clinical diagnostic and point-of-care applications.(c) 2023 Published by Elsevier B.V.
引用
收藏
页数:17
相关论文
共 165 条
[1]   RNA targeting with CRISPR-Cas13 [J].
Abudayyeh, Omar O. ;
Gootenberg, Jonathan S. ;
Essletzbichler, Patrick ;
Han, Shuo ;
Joung, Julia ;
Belanto, Joseph J. ;
Verdine, Vanessa ;
Cox, David B. T. ;
Kellner, Max J. ;
Regev, Aviv ;
Lander, Eric S. ;
Voytas, Daniel F. ;
Ting, Alice Y. ;
Zhang, Feng .
NATURE, 2017, 550 (7675) :280-+
[2]   C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector [J].
Abudayyeh, Omar O. ;
Gootenberg, Jonathan S. ;
Konermann, Silvana ;
Joung, Julia ;
Slaymaker, Ian M. ;
Cox, David B. T. ;
Shmakov, Sergey ;
Makarova, Kira S. ;
Semenova, Ekaterina ;
Minakhin, Leonid ;
Severinov, Konstantin ;
Regev, Aviv ;
Lander, Eric S. ;
Koonin, Eugene V. ;
Zhang, Feng .
SCIENCE, 2016, 353 (6299)
[3]   The CRISPR tool kit for genome editing and beyond [J].
Adli, Mazhar .
NATURE COMMUNICATIONS, 2018, 9
[4]   Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies [J].
Aman, Rashid ;
Mahas, Ahmed ;
Mahfouz, Magdy .
ACS SYNTHETIC BIOLOGY, 2020, 9 (06) :1226-1233
[5]   Simplified Cas13-based assays for the fast identification of SARS-CoV-2 and its variants [J].
Arizti-Sanz, Jon ;
Bradley, A'Doriann ;
Zhang, Yibin B. ;
Boehm, Chloe K. ;
Freije, Catherine A. ;
Grunberg, Michelle E. ;
Kosoko-Thoroddsen, Tinna-Solveig F. ;
Welch, Nicole L. ;
Pillai, Priya P. ;
Mantena, Sreekar ;
Kim, Gaeun ;
Uwanibe, Jessica N. ;
John, Oluwagboadurami G. ;
Eromon, Philomena E. ;
Kocher, Gregory ;
Gross, Robin ;
Lee, Justin S. ;
Hensley, Lisa E. ;
MacInnis, Bronwyn L. ;
Johnson, Jeremy ;
Springer, Michael ;
Happi, Christian T. ;
Sabeti, Pardis C. ;
Myhrvold, Cameron .
NATURE BIOMEDICAL ENGINEERING, 2022, 6 (08) :932-+
[6]   SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies [J].
Barnes, Christopher O. ;
Jette, Claudia A. ;
Abernathy, Morgan E. ;
Dam, Kim-Marie A. ;
Esswein, Shannon R. ;
Gristick, Harry B. ;
Malyutin, Andrey G. ;
Sharaf, Naima G. ;
Huey-Tubman, Kathryn E. ;
Lee, Yu E. ;
Robbiani, Davide F. ;
Nussenzweig, Michel C. ;
West, Anthony P., Jr. ;
Bjorkman, Pamela J. .
NATURE, 2020, 588 (7839) :682-+
[7]   Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics [J].
Barton, Michael, I ;
MacGowan, Stuart A. ;
Kutuzov, Mikhail A. ;
Dushek, Omer ;
Barton, Geoffrey John ;
van der Merwe, P. Anton .
ELIFE, 2021, 10
[8]   Detection and Discrimination of Single Nucleotide Polymorphisms by Quantification of CRISPR-Cas Catalytic Efficiency [J].
Blanluet, Charles ;
Huyke, Diego A. ;
Ramachandran, Ashwin ;
Avaro, Alexandre S. ;
Santiago, Juan G. .
ANALYTICAL CHEMISTRY, 2022, 94 (43) :15117-15123
[9]   CRISPR-Cas12-based detection of SARS-CoV-2 [J].
Broughton, James P. ;
Deng, Xianding ;
Yu, Guixia ;
Fasching, Clare L. ;
Servellita, Venice ;
Singh, Jasmeet ;
Miao, Xin ;
Streithorst, Jessica A. ;
Granados, Andrea ;
Sotomayor-Gonzalez, Alicia ;
Zorn, Kelsey ;
Gopez, Allan ;
Hsu, Elaine ;
Gu, Wei ;
Miller, Steve ;
Pan, Chao-Yang ;
Guevara, Hugo ;
Wadford, Debra A. ;
Chen, Janice S. ;
Chiu, Charles Y. .
NATURE BIOTECHNOLOGY, 2020, 38 (07) :870-+
[10]   BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection [J].
Cao, Yunlong ;
Yisimayi, Ayijiang ;
Jian, Fanchong ;
Song, Weiliang ;
Xiao, Tianhe ;
Wang, Lei ;
Du, Shuo ;
Wang, Jing ;
Li, Qianqian ;
Chen, Xiaosu ;
Yu, Yuanling ;
Wang, Peng ;
Zhang, Zhiying ;
Liu, Pulan ;
An, Ran ;
Hao, Xiaohua ;
Wang, Yao ;
Feng, Rui ;
Sun, Haiyan ;
Zhao, Lijuan ;
Zhang, Wen ;
Zhao, Dong ;
Zheng, Jiang ;
Yu, Lingling ;
Li, Can ;
Zhang, Na ;
Wang, Rui ;
Niu, Xiao ;
Yang, Sijie ;
Song, Xuetao ;
Chai, Yangyang ;
Hu, Ye ;
Shi, Yansong ;
Zheng, Linlin ;
Li, Zhiqiang ;
Gu, Qingqing ;
Shao, Fei ;
Huang, Weijin ;
Jin, Ronghua ;
Shen, Zhongyang ;
Wang, Youchun ;
Wang, Xiangxi ;
Xiao, Junyu ;
Xie, Xiaoliang Sunney .
NATURE, 2022, 608 (7923) :593-+